Sophia Delicou: A Shift Toward Function-Centered Care for Patients with Hemoglobinopathies
Sophia Delicou, Head of Thalassemia and Sickle Cell Unit, Head of the Expertise Center of Hemoglobin Diseases and Their Complications at Hippokrateio General Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Mediterranean Journal of Hematology and Infectious Diseases, adding:
“New Publication Announcement!
I’m pleased to share our latest publication in the Mediterranean Journal of Hematology and Infectious Diseases.
Our work explores the emerging challenge of aging in patients with thalassemia and sickle cell disease, proposing a gerontological framework to better understand and manage the growing population of adults living beyond midlife with these conditions.
Key insights:
- Hemoglobinopathies are increasingly becoming lifelong chronic conditions, with more patients reaching their 50s and beyond
- There is a shift from acute, disease-centered care to managing multimorbidity and functional decline
- Clinical priorities should include frailty, cognition, quality of life, and patient-centered outcomes
- Multidisciplinary and integrated care models are essential for optimal long-term management
This work highlights the need to rethink traditional care models and align them with the realities of aging with complex chronic diseases.
Grateful to collaborate with such a dedicated multidisciplinary team.”
Title: Aging with thalassemia and sickle cell disease: A gerontological model of accelerated multimorbidity and function-centered care beyond midlife
Authors: Sophia Delicou, Ioannis Ilias, Athanasia Kapota, Elena Papatheodorou, Maria Moraki, Aikaterini Xydaki, Alexandra Mika, Panagiota Giannou, Irene Kouroukli, Theodoros Aforozis, Myrto Palkopoulou, Christos Savvidis, Iliana Mani, Constantina Aggeli, John Koskinas
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 15:21Kanchan K Banerjee: Rusfertide Earns NCCN Category 1 Recommendation for Polycythemia Vera
-
Sep 29, 2026, 15:06Faizan Khan։ The Worldwide Burden of Venous Thromboembolism
-
Sep 29, 2026, 14:59Global Von Willebrand Disease Diversity Webinar Now Available on EHC YouTube – EHC
-
Sep 29, 2026, 14:43Mary Cushman: Apply to Shape Scientific Publishing as ISTH Associate Editor
-
Sep 29, 2026, 14:32Honoring Women Leaders Advancing Research, Care, and Innovation in Thrombosis and Hemostasis – Seminars in Thrombosis and Hemostasis
-
Sep 29, 2026, 14:20Nathan Connell: Key Takeaways from the 8th Aland Island Meeting on von Willebrand Disease
-
Sep 29, 2026, 14:09Mariusz Ratajczak: Are We Inadvertently Destroying the True Regenerative Power of PRP by Discarding the Plasma?
-
Sep 29, 2026, 14:00Nithin M: Proximal Splenic Artery Embolization Prior to Shunt-Directed Variceal Therapy
-
Sep 29, 2026, 13:12Wolfgang Miesbach: Teclistamab Targets the Source of Pathogenic Autoantibodies